Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1257
| Despition | MC4 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1739 | Human SYT3 Protein (AC1739) | 5 µg | inquiry |
| ACPP-1016 | Synthetic Nanodisc Human GnRHR Protein (AC1016) | 10 µg | inquiry |
| ACPP-1281 | ULK1 Blocking Peptide (AC1281) | 250 µg | inquiry |
| ACPP-1742 | Human PRND Protein (AC1742) | 2 µg | inquiry |
| ACPP-1294 | DCC Blocking Peptide (AC1294) | 250 µg | inquiry |
| ACPP-1583 | Human NRTN Protein (AC1583) | 5 µg | inquiry |
| ACPP-1074 | Myocilin Blocking Peptide (AC1074) | 250 µg | inquiry |
| ACPP-1695 | Human LGALS9 Protein (AC1695) | 2 µg | inquiry |
| ACPP-1661 | Human HEXA Protein, Sf9 (AC1661) | 2 µg | inquiry |
| ACPP-1381 | Human DTNBP1 Protein (AC1381) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.